$1.6B

RAISED BY SUMMIT COMPANIES
SINCE 2018

$1B

IN M&A AND LICENSING
SINCE 2018

200+

COMPANIES HAVE PRESENTED AT
THE SUMMIT
 

The OBIO® Investment Summit (OIS) and Early Technology Showcase (ETS) is a forum to connect global investors with growing companies, our best technology innovators and ecosystem partners. This edition also included the Pharma and MedTech Business Development Forum, which brought together Canada’s life science companies with corporate venture professionals to explore partnerships and licensing opportunities.

Since 2018, the OBIO® Investment Summit has presented high-quality, pre-vetted deal flow to global investors. In addition, the Summit’s Early Technology Showcase featured emerging companies coming out of Canada’s preeminent health research institutions.

In 2024, the OBIO® Investment Summit hosted:

 
 

160

VC & CORPORATE
VC INVESTORS

90

PRESENTING
COMPANIES

600+

PARTNERING
MEETINGS
 
 

2024 SUMMIT VENUE

The 2024 OBIO® Investment Summit took place on February 14-16, at the Schwartz Reisman Innovation Centre. The event space was located at 108 College Street, Toronto, ON M5G 0C6.

 
 

companies

Health science companies commercializing products and services in therapeutics, medical devices, diagnostics, digital health and health IT have the opportunity to pitch to global investors. An exclusive, invite-only event, the Summit provides a private environment for one-to-one meetings and relationship building with venture capital, strategic partners and investors specializing in health science.


INVESTORS:

Global investors have the opportunity to network with Canadian investors, build relationships with investible Canadian companies, meet our best technology innovators and make connections with Canada’s top research institutions.


*Fraud Alert* Please do not engage with anyone offering to sell lists of conference attendees. OBIO® does not sell attendee lists directly or through third parties.